Erythropoietin is a hypoxia-induced hormone that is essential for normal erythropoiesis. The
production of recombinant human erythropoietin (rHuEpo) has revolutionized the treatment …

In addition to its regulatory function in the formation of red blood cells (erythropoiesis) in
vertebrates, Erythropoietin (Epo) contributes to beneficial functions in a variety of non …

Erythropoietin (Epo) and its receptor (EpoR) are indispensable to erythropoiesis. Although
roles besides angiogenesis, such as neuroprotection and heart development, have been …

Erythropoietin (EPO) regulates mammalian erythropoiesis by binding to its transmembrane
receptor EPOR. Recent studies demonstrated functional EPOR expression in human cancer …

Myelodysplastic syndromes (MDS) are a constellation of different diseases sharing anemia
in the great majority of cases, and this cytopenia defines these pathologies and their most …

Previous reports have shown a direct effect of erythropoietin (Epo) on vascular smooth
muscle cells (VSMCs). Our aim was to assess expression of the Epo receptor (EpoR) on …

Erythropoietin (Epo) is a heavily glycosylated protein, with its main function being related to
erythropoiesis, where it controls red blood cell production via interaction with the Epo …

Azacytidine (5-AZA) is the standard first-choice treatment for high-risk myelodysplasia (MDS)
patients. However, the clinical outcome for those patients who interrupt treatment or whose …

Since apoptosis appeared to be related to neurodegenerative processes, neuroprotection
has been involved in investigation of therapeutic approaches focused upon …

Hypertension is the most significant complication from treatment with erythropoietin (Epo).
Can Epo-induced hypertension be eliminated? We examined systemic and local effects of …